The search found 3760 results.
Press
Imprivata Customers to Participate in Panel Sessions about Leveraging Imprivata’s Solutions to Give Care Providers Fast Access to Virtual Desktops and Patient Information at the Point of Care
Blog
Electronic Prescribing of Controlled Substances (EPCS) is urgently needed: 50% of prescribers don't check prescription drug monitoring program databases.
Blog
Secure Communications solutions are needed to solve healthcare's inefficient communications problems: secure communications promise improved patient care.
Partner
Conecto is a leading IT solution provider with more than 10 years’ experience delivering Imprivata and other clinical workflow improving system to the Nordic healthcare and local government.
Partner
Megadata SA was founded in 1996 to provide solutions and specialized services. During these years we have provided our customers:
Storage solutions.
Maintenance of equipment Unisys and open platforms.
Application Migration Services.
Studies of performance and capacity planning.
Software application monitoring and capacity planning.
Training.
Development of specialized applications.
Technical Support at Unisys platforms and open platforms.
Security Solutions
Blog
Introducing Electronic Prescribing of Controlled Substances is a great business move for pharmacists - read a pharmacist's arguments for EPCS adoption
Press
Lexington, Mass.—October 20, 2014—Imprivata® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today announced that the company will release the results for its third quarter ended September 30, 2014 after the market closes on Monday, November 3, 2014. Imprivata will hold a conference call for investors on November 3 at 5:00 p.m. EDT during which management will review highlights from the company's third quarter 2014 results, its business outlook and other matters.